FR2287228A1 - Nouveaux composes chimiques utiles en therapeutique humaine - Google Patents

Nouveaux composes chimiques utiles en therapeutique humaine

Info

Publication number
FR2287228A1
FR2287228A1 FR7531221A FR7531221A FR2287228A1 FR 2287228 A1 FR2287228 A1 FR 2287228A1 FR 7531221 A FR7531221 A FR 7531221A FR 7531221 A FR7531221 A FR 7531221A FR 2287228 A1 FR2287228 A1 FR 2287228A1
Authority
FR
France
Prior art keywords
alkyl
substd
thioureas
ureas
piperidyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
FR7531221A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Welfide Corp
Original Assignee
Welfide Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Welfide Corp filed Critical Welfide Corp
Publication of FR2287228A1 publication Critical patent/FR2287228A1/fr
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/56—Nitrogen atoms
    • C07D211/58—Nitrogen atoms attached in position 4

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Plural Heterocyclic Compounds (AREA)
FR7531221A 1974-10-12 1975-10-13 Nouveaux composes chimiques utiles en therapeutique humaine Withdrawn FR2287228A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP49117503A JPS5152176A (fr) 1974-10-12 1974-10-12

Publications (1)

Publication Number Publication Date
FR2287228A1 true FR2287228A1 (fr) 1976-05-07

Family

ID=14713345

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7531221A Withdrawn FR2287228A1 (fr) 1974-10-12 1975-10-13 Nouveaux composes chimiques utiles en therapeutique humaine

Country Status (7)

Country Link
JP (1) JPS5152176A (fr)
AU (1) AU8564375A (fr)
BE (1) BE834247A (fr)
DE (1) DE2545501A1 (fr)
FR (1) FR2287228A1 (fr)
NL (1) NL7511857A (fr)
SE (1) SE7511408L (fr)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2387955A1 (fr) * 1977-04-22 1978-11-17 Beecham Group Ltd Derives de l'aniline utilisables comme medicament
EP0035374A2 (fr) * 1980-03-01 1981-09-09 JOHN WYETH & BROTHER LIMITED Dérivés de la pipéridyl-urée, -thiourée et -guanidine, leurs intermédiaires, procédés pour leur préparation et compositions pharmaceutiques les contenant

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4203988A (en) 1975-11-12 1980-05-20 Merck & Co., Inc. Pyridinyl ureas and pharmaceutical use
US4722930A (en) * 1980-03-01 1988-02-02 John Wyeth And Brother Limited 3-benzoyl-1-[(oxo or thioheteroaryl-ylalkyl)-piperid-4-yl]ureas and derivatives
US4806552A (en) * 1980-03-01 1989-02-21 John Wyeth & Brother, Limited Pyridyl- and/or pyridoyl-(piperid-4-yl) ureas and analogues thereof
FI95572C (fi) * 1987-06-22 1996-02-26 Eisai Co Ltd Menetelmä lääkeaineena käyttökelpoisen piperidiinijohdannaisten tai sen farmaseuttisen suolan valmistamiseksi
AUPP818099A0 (en) * 1999-01-14 1999-02-11 Fujisawa Pharmaceutical Co., Ltd. New n-containing heterocyclic compounds
FR2802206B1 (fr) 1999-12-14 2005-04-22 Sod Conseils Rech Applic Derives de 4-aminopiperidine et leur utilisation en tant que medicament
WO2001068604A2 (fr) 2000-03-14 2001-09-20 Sepracor, Inc. Piperidines 3-substituees comprenant un groupement uree et procedes d'utilisation de ces dernieres
WO2004064738A2 (fr) 2003-01-16 2004-08-05 Acadia Pharmaceuticals Inc. Agonistes inverses selectifs pour le recepteur de la serotonine 2a/2c utilises comme agents therapeutiques contre les maladies neurodegeneratives
US20050261278A1 (en) 2004-05-21 2005-11-24 Weiner David M Selective serotonin receptor inverse agonists as therapeutics for disease
US7820695B2 (en) 2004-05-21 2010-10-26 Acadia Pharmaceuticals, Inc. Selective serotonin receptor inverse agonists as therapeutics for disease
US20090053329A1 (en) 2007-03-19 2009-02-26 Acadia Pharmaceuticals, Inc. Combinations of 5-ht2a inverse agonists and antagonists with antipsychotics
PT3325444T (pt) 2015-07-20 2021-09-22 Acadia Pharm Inc Métodos para preparar n-(4-fluorobenzil)-n-(1-metilpiperidina-4-il)-n'-(4-(2-metilpropiloxi)fenilmetil)carbamida e o seu sal de tartarato e forma polimórfica c
US10953000B2 (en) 2016-03-25 2021-03-23 Acadia Pharmaceuticals Inc. Combination of pimavanserin and cytochrome P450 modulators
WO2017165635A1 (fr) 2016-03-25 2017-09-28 Acadia Pharmaceuticals Inc. Association de pimavansérine et de modulateurs du cytochrome p450
EP3558311A1 (fr) 2016-12-20 2019-10-30 Acadia Pharmaceuticals Inc. Pimavansérine seule ou en association pour une utilisation dans le traitement de la psychose liée à la maladie d'alzheimer
EP3615028A1 (fr) 2017-04-28 2020-03-04 Acadia Pharmaceuticals Inc. Pimavansérine pour le traitement d'un trouble de contrôle des impulsions
US20210077479A1 (en) 2017-08-30 2021-03-18 Acadia Pharmaceuticals Inc. Formulations of pimavanserin
WO2024067304A1 (fr) * 2022-09-28 2024-04-04 瀚远医药有限公司 Composé à activité inhibitrice contre sigma2 et 5ht2a et utilisation

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2387955A1 (fr) * 1977-04-22 1978-11-17 Beecham Group Ltd Derives de l'aniline utilisables comme medicament
EP0035374A2 (fr) * 1980-03-01 1981-09-09 JOHN WYETH & BROTHER LIMITED Dérivés de la pipéridyl-urée, -thiourée et -guanidine, leurs intermédiaires, procédés pour leur préparation et compositions pharmaceutiques les contenant
EP0035374A3 (en) * 1980-03-01 1981-11-11 John Wyeth & Brother Limited Piperidyl - urea, - thiourea and - guanidine derivatives, and intermediates therefor, processes for preparing them and pharmaceutical compositions containing the derivatives

Also Published As

Publication number Publication date
AU8564375A (en) 1977-04-21
DE2545501A1 (de) 1976-04-22
JPS5152176A (fr) 1976-05-08
NL7511857A (nl) 1976-04-14
BE834247A (fr) 1976-02-02
SE7511408L (sv) 1976-04-13

Similar Documents

Publication Publication Date Title
FR2287228A1 (fr) Nouveaux composes chimiques utiles en therapeutique humaine
ES462062A1 (es) Un procedimiento para la preparacion de nuevos derivados de tetrahidroisoquinoleina.
IL96821A (en) 3-aminopiperidine derivatives, related nitrogen containing heterocycles and pharmaceutical compositions containing them
HUT35273A (en) Process for preparing epimeric azaerythromycin a derivatives and intermediary products thereof
MY103233A (en) Novel thiazole derivatives active on the cholinergic system, process for obtention and pharmaceutical compositions
ES452764A1 (es) Procedimiento para la preparacion de nuevos 2-tetrahidrofur-furil-6, 7-benzomorfanos disustituidos en 5,9-beta.
FR2024548A1 (en) Ortho-substd phenethylamines and medicaments
JPS51146466A (en) A process for preparing 1,3-dithiolan-2- iridenmalonate derivatives an d their use
GB1408198A (en) Antiviral compositions
NO981814D0 (no) Nye heterocykliske forbindelser, fremgangsmÕte ved deres fremstilling og farmas÷ytiske sammensetninger som inneholder dem
ES436399A1 (es) Procedimiento para la preparacion de tetraciclinas.
FR2150721A1 (en) Substd pyrimidines - hypotensives and analgesics
GB1310642A (en) Alpha-sulfo-and alpha-sulfoalkylacylcephalosporins
JPS5297934A (en) N#-arylsulfonyl-l-argininamides and their salts acceptable as medicine s
ES470442A1 (es) Ÿprocedimiento para la preparacion de derivados acilicosŸ
GB1384464A (en) Photographic material
ES419386A1 (es) Un procedimiento para la preparacion de nuevos derivados deindenopirrol.
FR2146962A1 (en) Aza-spirodecanones - useful in treating gastric disorders
ES374901A1 (es) Un procedimiento para producir derivados de benzomorfano.
ES442051A1 (es) Procedimiento para preparar aminoglicosidos de 2-deoxies- treptamina.
GB1388400A (en) Derivatives of alpha-aminocephalosporins
ES8708135A1 (es) Procedimiento para preparar compuestos diarilicos
ES8507513A1 (es) Un procedimiento para preparar derivados bis-dioxopiperazinicos
ES402285A1 (es) Procedimiento para la obtencion de composiciones farmaceu- ticas con actividad fibrinolitica o antifibrinolitica.
GB1207629A (en) Sydnone derivatives

Legal Events

Date Code Title Description
ST Notification of lapse